Peng George 4
4 · Ensysce Biosciences, Inc. · Filed Jul 1, 2021
Insider Transaction Report
Form 4
Peng George
Chief Financial Officer
Transactions
- Award
Warrants
2021-06-30$1.00/sh+15,000$15,000→ 15,000 totalExercise: $11.50From: 2021-07-30Exp: 2026-06-30→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]Reflects warrants of Ensysce Biosciences, Inc., formerly known as Leisure Acquisition Corp. (the "Issuer"), which were acquired from the Issuer at a price of $1.00 per warrant in a private placement that closed simultaneously with the closing of the Issuer's initial public offering which were later exchanged for warrants having the same terms, except that they are non-transferable other than to permitted transferees. Pursuant to the terms of the issuance, such warrants were not eligible to become exercisable unless the Issuer consummated its initial business combination which occurred on June 30, 2021. Mr. Peng served as the Issuer's Chief Financial Officer until the closing of the business combination.